<?xml version="1.0" encoding="UTF-8"?>
<p>Larifan (produced by Larifan Ltd., Latvia) is a drug containing the replicative form of bacteriophage f2 dsRNA, obtained from 
 <italic>Escherichia coli</italic> cells infected with the phage. Based on phage dsRNA, several dosage forms have been developed: the injection form of Larifan, an antiviral and immunostimulatory drug with antitumor activity; Larifan ointment and suppositories [
 <xref ref-type="bibr" rid="CR54">54</xref>].
</p>
